INTEGRATED BIOPHARMA INC Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Integrated Biopharma Inc quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q3 2018 to Q3 2024.
  • Integrated Biopharma Inc Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2024 was $95K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $95K Sep 30, 2024 10-Q 2024-11-13
Q2 2021 $216K Jun 30, 2021 10-K 2021-09-02
Q4 2018 $493K Dec 31, 2018 10-Q 2019-02-13
Q3 2018 $527K Sep 30, 2018 10-Q 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.